This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Care ETFs: Elixir for Your Portfolio

With a 4.3% increase during February, the cost of medical care in the U.S. continues to increase at nearly double the 2.4% pace of overall prices. So, it's no surprise that exchange-traded funds are being launched to invest in the companies benefiting from this pricing power.

On March 12, XShares Advisors introduced one composite and eight new sub-industry-specific health care funds. These were added to the five HealthShares ETFs that have been in the XShares product portfolio since Jan. 23.

With the addition of these 14 health and biotech related ETFs, there are now 37 funds covering this sector. No other specific sector has as many ETFs.

Let's say you are reading a scientific journal about breakthroughs with promising new cancer drugs, and you decide to invest in a biotech company that specializes in cancer drugs. Instead of betting the house on a single company, you can now buy the HealthShares Cancer ETF (HHK). This fund is comprised of 64.9% pharmaceutical stocks and 35.1% biotechnology stocks. By making one investment in 22 companies actively seeking novel cancer treatments, the odds of holding the one stock that hits it big are increased.

Of course, the opposite can also true. Biotechnology and pharmaceutical stocks tend to be highly volatile, as potential new drugs succeed or fail at each stage of their clinical trials. So, if a proposed drug disappoints in trials or an existing drug is pulled from the market due to unacceptable side effects, expect to participate in the loss.

If your other investments are causing anxiety, depression and loss of sleep, or you are just plain absent-minded, the HealthShares Neuroscience ETF (HHN) holds the companies that want to bring help.

New XShares Advisors Funds
Fund Ticker Inception
HealthShares Autoimmune-Inflammation ETF HHA 3/12/2007
HealthShares Cancer ETF HHK 3/12/2007
HealthShares Cardiology ETF HRD 3/12/2007
HealthShares Composite ETF HHQ 3/12/2007
HealthShares GI/Gender Health ETF HHU 3/12/2007
HealthShares Metabolic-Endocrine Disorders ETF HHM 3/12/2007
HealthShares Neuroscience ETF HHN 3/12/2007
HealthShares Ophthamology ETF HHZ 3/12/2007
HealthShares Respitory/Pulmonary ETF HHR 3/12/2007
HealthShares Cardiology Devices ETF HHE 1/23/2007
HealthShares Diagnostic ETF HHD 1/23/2007
HealthShares Emerging Cancer ETF HHJ 1/23/2007
HealthShares Enabling Technology ETF HHV 1/23/2007
HealthShares Patient Care Services ETF HHB 1/23/2007

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs